These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. Colson ER; Horwitz RI; Bia FJ; Viscoli CM Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453 [TBL] [Abstract][Full Text] [Related]
43. Research study of combination AIDS therapies underway. AIDS Patient Care STDS; 1996 Apr; 10(2):132. PubMed ID: 11361697 [No Abstract] [Full Text] [Related]
44. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas]. Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038 [TBL] [Abstract][Full Text] [Related]
45. New drug for AIDS and advanced ARC patients. Arman F Dimens Crit Care Nurs; 1990; 9(3):128. PubMed ID: 2187660 [No Abstract] [Full Text] [Related]
46. [Placebos as AIDS therapy, continued]. Meijer van Putten JB Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2093. PubMed ID: 9644003 [No Abstract] [Full Text] [Related]
47. Resolution of intestinal cryptosporidiosis after treatment of AIDS with AZT. Greenberg RE; Mir R; Bank S; Siegal FP Gastroenterology; 1989 Nov; 97(5):1327-30. PubMed ID: 2486062 [TBL] [Abstract][Full Text] [Related]
48. The use of zidovudine. Wood MJ Int J Dermatol; 1989 Jun; 28(5):308-10. PubMed ID: 2666322 [No Abstract] [Full Text] [Related]
49. Methodological issues in AIDS clinical trials. Application of the combination index method in the design of a clinical antiretroviral trial: ACTG 068. Mildvan D; Ruprecht R; Krown S; Pettinelli C J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S111-3 discussion S114-9. PubMed ID: 2231291 [No Abstract] [Full Text] [Related]
50. Studying treatments for AIDS: new challenges for clinical trials--a panel discussion at the 1990 annual meeting of the Society for Clinical Trials. Ellenberg SS; Cooper E; Eigo J; Finkelstein DM; Hoth DF; Nusinoff-Lehrman S; Sacks H Control Clin Trials; 1992 Aug; 13(4):272-92. PubMed ID: 1330433 [No Abstract] [Full Text] [Related]
51. Living with AIDS--changes and challenges in the care of HIV disease. Scoular AB Scott Med J; 1990 Oct; 35(5):131-2. PubMed ID: 2255891 [No Abstract] [Full Text] [Related]
52. HIV therapeutics: an emerging science. Bartlett JA JAMA; 1988 Nov; 260(20):3051-2. PubMed ID: 3054186 [No Abstract] [Full Text] [Related]
54. Problems of chemotherapy in multiply-infected AIDS patients. Gazzard BG Trans R Soc Trop Med Hyg; 1990; 84 Suppl 1():25-33. PubMed ID: 2201110 [TBL] [Abstract][Full Text] [Related]
55. Controversial findings of VA AZT trial. J Am Osteopath Assoc; 1991 Apr; 91(4):332. PubMed ID: 1874641 [No Abstract] [Full Text] [Related]
56. Zidovudine and the natural history of AIDS. N Engl J Med; 1991 Oct; 325(18):1311-3. PubMed ID: 1922230 [No Abstract] [Full Text] [Related]
57. The next step in AIDS treatment. Maddox J Nature; 1993 Apr; 362(6420):493. PubMed ID: 8096626 [No Abstract] [Full Text] [Related]
58. Zidovudine in early HIV disease. McLeod GX Hosp Pract (Off Ed); 1993 Mar; 28(3A):9-10. PubMed ID: 8450007 [No Abstract] [Full Text] [Related]
59. Wider use of AIDS drugs advocated. Marx JL Science; 1989 Aug; 245(4920):811. PubMed ID: 2672331 [No Abstract] [Full Text] [Related]
60. AIDS administrators plan crisis meeting over future of AZT. Dickson D; Macilwain C Nature; 1993 Apr; 362(6420):483. PubMed ID: 8464482 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]